AEZS:
Analysis & Opinions
-
February 08, 2013
Vical Inc. (VICL) suffered a net loss per share of 9 cents in the fourth quarter of 2012, narrower than the Zacks ...
-
January 17, 2013
Amarin Corporation plc (AMRN), recently announced that the notice of patent allowance for US application serial ...
-
January 16, 2013
Ironwood Pharmaceuticals, Inc.'s (IRWD) fourth-quarter 2012 loss of 41 cents per share compared unfavorably with the ...
-
January 02, 2013
Aeterna Zentaris Inc. (AEZS) recently announced that its oncology candidate, AEZS-108 (doxorubicin peptide ...
-
August 17, 2011
In the wake of big pharma's patent cliff and slowing R&D spending, the biotech sector is looking good for investors.
-
May 27, 2010
ASCO is a major event for the pharmaceutical and biotech industry, and these stocks could shine in the limelight.
